Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Acute × Thioguanine × Clear all

NCT06351306 2025-03-24

DEC-C and Thioguanine for R/R AML

Phase 2 Withdrawn

Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute